Skip Ribbon Commands
Skip to main content
Sign In
{{'GLOBAL_MESSAGE_HEADLINE' | translate}}
{{'GLOBAL_MESSAGE_CHOOSE_LANG' | translate}}
en
日本語
中文
{{'GLOBAL_MESSAGE_OR' | translate}}
{{'GLOBAL_MESSAGE_SET_COUNTRY' | translate}}
{{'ELOQUA_BANNER_DECLINE_CONFIRM' | translate}}
{{'ELOQUA_BANNER_DECLINE_CONFIRM_CLOSE' | translate}}
{{'ELOQUA_BANNER_ACCEPT' | translate}}
{{'ELOQUA_BANNER_DECLINE' | translate}}

​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​

Unlocking the Potential of Blood and Cells
Our solutions touch a patient's life every second of every day

We provide medical technology and insights to empower blood- and cell-based therapies around the world.

From lifesaving transfusions to next-generation therapies that treat cancer and other diseases, blood and cells are essential medicine.

At Terumo Blood and Cell Technologies, our 7,900+ team members play an important role in the collection, processing, development, and delivery of those blood- and cell-based treatments — so our customers can help more patients access the highest standards of care.

2 minutes

Our purpose: Unlocking potential

We see potential at every turn as we build on what we’ve learned and invest in what’s possible: new therapies, a plentiful world blood supply, game-changing partnerships, and solutions that impact lives.

We provide medical technology and insights to empower blood- and cell-based therapies around the world.

From lifesaving transfusions to next-generation therapies that treat cancer and other diseases, blood and cells are essential medicine.

At Terumo Blood and Cell Technologies, our 7,900+ team members play an important role in the collection, processing, development, and delivery of those blood- and cell-based treatments — so our customers can help more patients access the highest standards of care.

2 minutes

Our purpose: Unlocking potential

We see potential at every turn as we build on what we’ve learned and invest in what’s possible: new therapies, a plentiful world blood supply, game-changing partnerships, and solutions that impact lives.

Supporting healthcare's frontlines

desktop

Global Blood Solutions

Blood Collection Centers

With innovation, automation, and insights, we empower centers to overcome challenges, improve donor experience, and make the most of each donation.

Learn more >

Therapeutic Apheresis

Hospitals and Healthcare Providers

Medical teams deliver hope to patients, and we’re here to help via industry-leading apheresis and cell collection solutions and decades of experience.

Learn more >

Cell Therapy Technologies

Biotechnology Companies and Researchers

Cell and gene therapy developers turn to us to optimize processes, from starting material collection to automation that scales for commercialization.

Learn more >

Global Blood Solutions

Blood Collection Centers

With innovation, automation, and insights, we empower centers to overcome challenges, improve donor experience, and make the most of each donation.

Learn more >

Therapeutic Apheresis

Hospitals and Healthcare Providers

Medical teams deliver hope to patients, and we’re here to help via industry-leading apheresis and cell collection solutions and decades of experience.

Learn more >
,

Cell Therapy Technologies

Biotechnology Companies and Researchers

Cell and gene therapy developers turn to us to optimize processes, from starting material collection to automation that scales for commercialization.

Learn more >

Latest news

Terumo Blood and Cell Technologies and Sanquin to Automate Whole Blood Processing Across the Netherlands

Terumo Blood and Cell Technologies collaborates with Nova Biomedical to bring automated cell culture sensing to Quantum Flex

Anthony Nolan to open stem cell collection centre to help patients and enable cell and gene therapy research

Terumo Blood and Cell Technologies and Charles River Demonstrate Versatility of FINIA Automated Cell and Gene Therapy Fill and Finish Platform

Terumo Blood and Cell Technologies celebrates 60 years as a community-first Colorado company

Terumo BCT supports research about pregnancy with sickle cell disease

Terumo Blood and Cell Technologies names Mani Venkatesh the VP of Digital Transformation

FDA clears the individualized nomogram for Rika Plasma Donation System

Terumo Blood and Cell Technologies introduces its EU Sickle Cell Disease Manifesto

{{'SEARCH_MODAL_TITLE' | translate }}
{{'SEARCH_MODAL_OR' | translate }}

{{'SEARCH_MODAL_BROWSE' | translate }} {{'SEARCH_MODAL_ENLABEL' | translate }}
{{'SEARCH_MODAL_CHOOSE_LANGUAGE' | translate }} {{'SEARCH_MODAL_CHANGE_LANGUAGE' | translate }}
{{$index+1}}. {{s.label}}